nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—CA14—Lacosamide—epilepsy syndrome	0.119	0.183	CbGbCtD
Zoledronate—CA14—Acetazolamide—epilepsy syndrome	0.0818	0.126	CbGbCtD
Zoledronate—CA14—Zonisamide—epilepsy syndrome	0.0756	0.116	CbGbCtD
Zoledronate—CA2—Lacosamide—epilepsy syndrome	0.0682	0.105	CbGbCtD
Zoledronate—CA12—Acetazolamide—epilepsy syndrome	0.0581	0.0892	CbGbCtD
Zoledronate—CA12—Zonisamide—epilepsy syndrome	0.0537	0.0826	CbGbCtD
Zoledronate—CA2—Acetazolamide—epilepsy syndrome	0.047	0.0721	CbGbCtD
Zoledronate—CA2—Zonisamide—epilepsy syndrome	0.0434	0.0668	CbGbCtD
Zoledronate—CA12—Topiramate—epilepsy syndrome	0.0392	0.0602	CbGbCtD
Zoledronate—ABCC1—Phenobarbital—epilepsy syndrome	0.0334	0.0512	CbGbCtD
Zoledronate—CA2—Topiramate—epilepsy syndrome	0.0317	0.0486	CbGbCtD
Zoledronate—GGPS1—hindbrain—epilepsy syndrome	0.00481	0.099	CbGeAlD
Zoledronate—GGPS1—brainstem—epilepsy syndrome	0.00275	0.0568	CbGeAlD
Zoledronate—GGPS1—telencephalon—epilepsy syndrome	0.00244	0.0504	CbGeAlD
Zoledronate—GGPS1—medulla oblongata—epilepsy syndrome	0.00192	0.0396	CbGeAlD
Zoledronate—GGPS1—midbrain—epilepsy syndrome	0.00176	0.0362	CbGeAlD
Zoledronate—GGPS1—spinal cord—epilepsy syndrome	0.00171	0.0353	CbGeAlD
Zoledronate—GGPS1—head—epilepsy syndrome	0.00152	0.0314	CbGeAlD
Zoledronate—CA14—telencephalon—epilepsy syndrome	0.00146	0.0301	CbGeAlD
Zoledronate—GGPS1—nervous system—epilepsy syndrome	0.00144	0.0297	CbGeAlD
Zoledronate—GGPS1—central nervous system—epilepsy syndrome	0.00139	0.0286	CbGeAlD
Zoledronate—GGPS1—cerebellum—epilepsy syndrome	0.00136	0.028	CbGeAlD
Zoledronate—CA12—forebrain—epilepsy syndrome	0.00124	0.0255	CbGeAlD
Zoledronate—FDPS—forebrain—epilepsy syndrome	0.00123	0.0253	CbGeAlD
Zoledronate—CA2—hindbrain—epilepsy syndrome	0.00115	0.0237	CbGeAlD
Zoledronate—CA14—medulla oblongata—epilepsy syndrome	0.00115	0.0237	CbGeAlD
Zoledronate—CA12—telencephalon—epilepsy syndrome	0.00114	0.0235	CbGeAlD
Zoledronate—FDPS—telencephalon—epilepsy syndrome	0.00113	0.0232	CbGeAlD
Zoledronate—GGPS1—brain—epilepsy syndrome	0.0011	0.0227	CbGeAlD
Zoledronate—CA14—midbrain—epilepsy syndrome	0.00105	0.0216	CbGeAlD
Zoledronate—CA14—spinal cord—epilepsy syndrome	0.00102	0.0211	CbGeAlD
Zoledronate—FDPS—medulla oblongata—epilepsy syndrome	0.000885	0.0182	CbGeAlD
Zoledronate—CA14—cerebellum—epilepsy syndrome	0.000812	0.0167	CbGeAlD
Zoledronate—FDPS—midbrain—epilepsy syndrome	0.000809	0.0167	CbGeAlD
Zoledronate—FDPS—spinal cord—epilepsy syndrome	0.00079	0.0163	CbGeAlD
Zoledronate—CA12—head—epilepsy syndrome	0.00071	0.0146	CbGeAlD
Zoledronate—FDPS—head—epilepsy syndrome	0.000702	0.0145	CbGeAlD
Zoledronate—CA12—nervous system—epilepsy syndrome	0.000673	0.0139	CbGeAlD
Zoledronate—FDPS—nervous system—epilepsy syndrome	0.000665	0.0137	CbGeAlD
Zoledronate—CA14—brain—epilepsy syndrome	0.000659	0.0136	CbGeAlD
Zoledronate—CA2—brainstem—epilepsy syndrome	0.000659	0.0136	CbGeAlD
Zoledronate—ABCC1—telencephalon—epilepsy syndrome	0.000654	0.0135	CbGeAlD
Zoledronate—CA12—central nervous system—epilepsy syndrome	0.000648	0.0133	CbGeAlD
Zoledronate—FDPS—central nervous system—epilepsy syndrome	0.000641	0.0132	CbGeAlD
Zoledronate—CA2—forebrain—epilepsy syndrome	0.000636	0.0131	CbGeAlD
Zoledronate—FDPS—cerebellum—epilepsy syndrome	0.000626	0.0129	CbGeAlD
Zoledronate—CA2—telencephalon—epilepsy syndrome	0.000585	0.0121	CbGeAlD
Zoledronate—CA12—brain—epilepsy syndrome	0.000514	0.0106	CbGeAlD
Zoledronate—FDPS—brain—epilepsy syndrome	0.000509	0.0105	CbGeAlD
Zoledronate—CA2—medulla oblongata—epilepsy syndrome	0.00046	0.00947	CbGeAlD
Zoledronate—CA2—midbrain—epilepsy syndrome	0.00042	0.00866	CbGeAlD
Zoledronate—CA2—spinal cord—epilepsy syndrome	0.00041	0.00845	CbGeAlD
Zoledronate—CA2—head—epilepsy syndrome	0.000364	0.00751	CbGeAlD
Zoledronate—ABCC1—cerebellum—epilepsy syndrome	0.000364	0.00749	CbGeAlD
Zoledronate—CA2—nervous system—epilepsy syndrome	0.000345	0.00712	CbGeAlD
Zoledronate—CA2—central nervous system—epilepsy syndrome	0.000333	0.00685	CbGeAlD
Zoledronate—CA2—cerebellum—epilepsy syndrome	0.000325	0.0067	CbGeAlD
Zoledronate—ABCC1—brain—epilepsy syndrome	0.000295	0.00609	CbGeAlD
Zoledronate—Risedronate—PTGS2—epilepsy syndrome	0.000288	0.529	CrCbGaD
Zoledronate—CA2—brain—epilepsy syndrome	0.000264	0.00544	CbGeAlD
Zoledronate—Clodronate—PTGS2—epilepsy syndrome	0.000257	0.471	CrCbGaD
Zoledronate—CA12—Metabolism—ADSL—epilepsy syndrome	5.98e-05	0.000712	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CACNA1D—epilepsy syndrome	5.97e-05	0.000711	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GLUL—epilepsy syndrome	5.87e-05	0.000698	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ABCB1—epilepsy syndrome	5.85e-05	0.000696	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HSD17B4—epilepsy syndrome	5.81e-05	0.000691	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CACNA1D—epilepsy syndrome	5.76e-05	0.000685	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	5.74e-05	0.000682	CbGpPWpGaD
Zoledronate—CA14—Metabolism—KCNJ11—epilepsy syndrome	5.61e-05	0.000668	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CHRM3—epilepsy syndrome	5.61e-05	0.000668	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GBE1—epilepsy syndrome	5.61e-05	0.000668	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPP1R3C—epilepsy syndrome	5.61e-05	0.000668	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—TXNRD1—epilepsy syndrome	5.59e-05	0.000665	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CA13—epilepsy syndrome	5.56e-05	0.000662	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GPX1—epilepsy syndrome	5.44e-05	0.000647	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AQP1—epilepsy syndrome	5.42e-05	0.000645	CbGpPWpGaD
Zoledronate—CA12—Metabolism—TXNRD1—epilepsy syndrome	5.39e-05	0.000641	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	5.31e-05	0.000631	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ASAH1—epilepsy syndrome	5.28e-05	0.000628	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AQP1—epilepsy syndrome	5.23e-05	0.000622	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.21e-05	0.00062	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	5.17e-05	0.000615	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	5.17e-05	0.000615	CbGpPWpGaD
Zoledronate—Anxiety—Pregabalin—epilepsy syndrome	5.16e-05	0.000239	CcSEcCtD
Zoledronate—Diarrhoea—Clonazepam—epilepsy syndrome	5.16e-05	0.000239	CcSEcCtD
Zoledronate—Anaemia—Gabapentin—epilepsy syndrome	5.15e-05	0.000238	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.14e-05	0.000238	CcSEcCtD
Zoledronate—CA2—Metabolism—STXBP1—epilepsy syndrome	5.13e-05	0.000611	CbGpPWpGaD
Zoledronate—Hypotension—Valproic Acid—epilepsy syndrome	5.13e-05	0.000237	CcSEcCtD
Zoledronate—Asthenia—Carbamazepine—epilepsy syndrome	5.13e-05	0.000237	CcSEcCtD
Zoledronate—Agitation—Gabapentin—epilepsy syndrome	5.12e-05	0.000237	CcSEcCtD
Zoledronate—Diarrhoea—Phenytoin—epilepsy syndrome	5.12e-05	0.000237	CcSEcCtD
Zoledronate—Discomfort—Pregabalin—epilepsy syndrome	5.11e-05	0.000237	CcSEcCtD
Zoledronate—Nausea—Fosphenytoin—epilepsy syndrome	5.11e-05	0.000236	CcSEcCtD
Zoledronate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.09e-05	0.000236	CcSEcCtD
Zoledronate—Angioedema—Gabapentin—epilepsy syndrome	5.09e-05	0.000236	CcSEcCtD
Zoledronate—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.09e-05	0.000236	CcSEcCtD
Zoledronate—Vomiting—Felbamate—epilepsy syndrome	5.08e-05	0.000235	CcSEcCtD
Zoledronate—Dry mouth—Pregabalin—epilepsy syndrome	5.06e-05	0.000234	CcSEcCtD
Zoledronate—Pruritus—Carbamazepine—epilepsy syndrome	5.05e-05	0.000234	CcSEcCtD
Zoledronate—Rash—Felbamate—epilepsy syndrome	5.04e-05	0.000233	CcSEcCtD
Zoledronate—ABCC1—Disease—PDXK—epilepsy syndrome	5.03e-05	0.000599	CbGpPWpGaD
Zoledronate—Eye disorder—Topiramate—epilepsy syndrome	5.03e-05	0.000233	CcSEcCtD
Zoledronate—Dermatitis—Felbamate—epilepsy syndrome	5.03e-05	0.000233	CcSEcCtD
Zoledronate—Malaise—Gabapentin—epilepsy syndrome	5.03e-05	0.000233	CcSEcCtD
Zoledronate—Vertigo—Gabapentin—epilepsy syndrome	5.01e-05	0.000232	CcSEcCtD
Zoledronate—Headache—Felbamate—epilepsy syndrome	5e-05	0.000232	CcSEcCtD
Zoledronate—CA2—Metabolism—NT5E—epilepsy syndrome	5e-05	0.000595	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALAD—epilepsy syndrome	5e-05	0.000595	CbGpPWpGaD
Zoledronate—Confusional state—Pregabalin—epilepsy syndrome	5e-05	0.000232	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5e-05	0.000231	CcSEcCtD
Zoledronate—Flushing—Topiramate—epilepsy syndrome	5e-05	0.000231	CcSEcCtD
Zoledronate—Cardiac disorder—Topiramate—epilepsy syndrome	5e-05	0.000231	CcSEcCtD
Zoledronate—Syncope—Gabapentin—epilepsy syndrome	5e-05	0.000231	CcSEcCtD
Zoledronate—Leukopenia—Gabapentin—epilepsy syndrome	4.99e-05	0.000231	CcSEcCtD
Zoledronate—Dizziness—Clonazepam—epilepsy syndrome	4.98e-05	0.000231	CcSEcCtD
Zoledronate—Nausea—Vigabatrin—epilepsy syndrome	4.98e-05	0.000231	CcSEcCtD
Zoledronate—Vomiting—Zonisamide—epilepsy syndrome	4.97e-05	0.00023	CcSEcCtD
Zoledronate—Insomnia—Valproic Acid—epilepsy syndrome	4.96e-05	0.00023	CcSEcCtD
Zoledronate—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.96e-05	0.00023	CcSEcCtD
Zoledronate—Oedema—Pregabalin—epilepsy syndrome	4.96e-05	0.00023	CcSEcCtD
Zoledronate—Asthenia—Lamotrigine—epilepsy syndrome	4.95e-05	0.000229	CcSEcCtD
Zoledronate—Dizziness—Phenytoin—epilepsy syndrome	4.95e-05	0.000229	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	4.93e-05	0.000587	CbGpPWpGaD
Zoledronate—Rash—Zonisamide—epilepsy syndrome	4.93e-05	0.000228	CcSEcCtD
Zoledronate—Infection—Pregabalin—epilepsy syndrome	4.93e-05	0.000228	CcSEcCtD
Zoledronate—Paraesthesia—Valproic Acid—epilepsy syndrome	4.93e-05	0.000228	CcSEcCtD
Zoledronate—Palpitations—Gabapentin—epilepsy syndrome	4.92e-05	0.000228	CcSEcCtD
Zoledronate—Dermatitis—Zonisamide—epilepsy syndrome	4.92e-05	0.000228	CcSEcCtD
Zoledronate—Dizziness—Oxcarbazepine—epilepsy syndrome	4.92e-05	0.000228	CcSEcCtD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—epilepsy syndrome	4.92e-05	0.000585	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—KCNJ11—epilepsy syndrome	4.91e-05	0.000584	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CHRM3—epilepsy syndrome	4.91e-05	0.000584	CbGpPWpGaD
Zoledronate—Nausea—Diazepam—epilepsy syndrome	4.9e-05	0.000227	CcSEcCtD
Zoledronate—Loss of consciousness—Gabapentin—epilepsy syndrome	4.9e-05	0.000227	CcSEcCtD
Zoledronate—Headache—Zonisamide—epilepsy syndrome	4.9e-05	0.000227	CcSEcCtD
Zoledronate—Dyspnoea—Valproic Acid—epilepsy syndrome	4.89e-05	0.000226	CcSEcCtD
Zoledronate—Diarrhoea—Carbamazepine—epilepsy syndrome	4.89e-05	0.000226	CcSEcCtD
Zoledronate—Angiopathy—Topiramate—epilepsy syndrome	4.89e-05	0.000226	CcSEcCtD
Zoledronate—Pruritus—Lamotrigine—epilepsy syndrome	4.88e-05	0.000226	CcSEcCtD
Zoledronate—Shock—Pregabalin—epilepsy syndrome	4.88e-05	0.000226	CcSEcCtD
Zoledronate—Somnolence—Valproic Acid—epilepsy syndrome	4.88e-05	0.000226	CcSEcCtD
Zoledronate—Immune system disorder—Topiramate—epilepsy syndrome	4.86e-05	0.000225	CcSEcCtD
Zoledronate—Nervous system disorder—Pregabalin—epilepsy syndrome	4.86e-05	0.000225	CcSEcCtD
Zoledronate—Cough—Gabapentin—epilepsy syndrome	4.86e-05	0.000225	CcSEcCtD
Zoledronate—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.86e-05	0.000225	CcSEcCtD
Zoledronate—Mediastinal disorder—Topiramate—epilepsy syndrome	4.85e-05	0.000225	CcSEcCtD
Zoledronate—Tachycardia—Pregabalin—epilepsy syndrome	4.84e-05	0.000224	CcSEcCtD
Zoledronate—Chills—Topiramate—epilepsy syndrome	4.83e-05	0.000224	CcSEcCtD
Zoledronate—Dyspepsia—Valproic Acid—epilepsy syndrome	4.83e-05	0.000224	CcSEcCtD
Zoledronate—Convulsion—Gabapentin—epilepsy syndrome	4.83e-05	0.000224	CcSEcCtD
Zoledronate—Skin disorder—Pregabalin—epilepsy syndrome	4.82e-05	0.000223	CcSEcCtD
Zoledronate—Hypertension—Gabapentin—epilepsy syndrome	4.81e-05	0.000223	CcSEcCtD
Zoledronate—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.8e-05	0.000222	CcSEcCtD
Zoledronate—Vomiting—Clonazepam—epilepsy syndrome	4.79e-05	0.000222	CcSEcCtD
Zoledronate—CA2—Metabolism—CACNA1A—epilepsy syndrome	4.77e-05	0.000568	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALDH7A1—epilepsy syndrome	4.77e-05	0.000568	CbGpPWpGaD
Zoledronate—Decreased appetite—Valproic Acid—epilepsy syndrome	4.77e-05	0.000221	CcSEcCtD
Zoledronate—GGPS1—Metabolism—AGT—epilepsy syndrome	4.77e-05	0.000567	CbGpPWpGaD
Zoledronate—Alopecia—Topiramate—epilepsy syndrome	4.76e-05	0.00022	CcSEcCtD
Zoledronate—Vomiting—Phenytoin—epilepsy syndrome	4.76e-05	0.00022	CcSEcCtD
Zoledronate—Rash—Clonazepam—epilepsy syndrome	4.75e-05	0.00022	CcSEcCtD
Zoledronate—Dermatitis—Clonazepam—epilepsy syndrome	4.75e-05	0.00022	CcSEcCtD
Zoledronate—Arthralgia—Gabapentin—epilepsy syndrome	4.74e-05	0.00022	CcSEcCtD
Zoledronate—Myalgia—Gabapentin—epilepsy syndrome	4.74e-05	0.00022	CcSEcCtD
Zoledronate—Chest pain—Gabapentin—epilepsy syndrome	4.74e-05	0.00022	CcSEcCtD
Zoledronate—Nausea—Felbamate—epilepsy syndrome	4.74e-05	0.00022	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.74e-05	0.000219	CcSEcCtD
Zoledronate—Vomiting—Oxcarbazepine—epilepsy syndrome	4.73e-05	0.000219	CcSEcCtD
Zoledronate—CA12—Metabolism—KCNJ11—epilepsy syndrome	4.73e-05	0.000563	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CHRM3—epilepsy syndrome	4.73e-05	0.000563	CbGpPWpGaD
Zoledronate—Fatigue—Valproic Acid—epilepsy syndrome	4.73e-05	0.000219	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	4.73e-05	0.000563	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	4.73e-05	0.000563	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	4.73e-05	0.000563	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	4.73e-05	0.000563	CbGpPWpGaD
Zoledronate—Anxiety—Gabapentin—epilepsy syndrome	4.73e-05	0.000219	CcSEcCtD
Zoledronate—Anorexia—Pregabalin—epilepsy syndrome	4.73e-05	0.000219	CcSEcCtD
Zoledronate—Dizziness—Carbamazepine—epilepsy syndrome	4.72e-05	0.000219	CcSEcCtD
Zoledronate—Diarrhoea—Lamotrigine—epilepsy syndrome	4.72e-05	0.000219	CcSEcCtD
Zoledronate—Headache—Clonazepam—epilepsy syndrome	4.72e-05	0.000219	CcSEcCtD
Zoledronate—Rash—Phenytoin—epilepsy syndrome	4.72e-05	0.000218	CcSEcCtD
Zoledronate—Mental disorder—Topiramate—epilepsy syndrome	4.72e-05	0.000218	CcSEcCtD
Zoledronate—Dermatitis—Phenytoin—epilepsy syndrome	4.71e-05	0.000218	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.71e-05	0.000218	CcSEcCtD
Zoledronate—Rash—Oxcarbazepine—epilepsy syndrome	4.69e-05	0.000217	CcSEcCtD
Zoledronate—Constipation—Valproic Acid—epilepsy syndrome	4.69e-05	0.000217	CcSEcCtD
Zoledronate—Pain—Valproic Acid—epilepsy syndrome	4.69e-05	0.000217	CcSEcCtD
Zoledronate—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.69e-05	0.000217	CcSEcCtD
Zoledronate—Headache—Phenytoin—epilepsy syndrome	4.69e-05	0.000217	CcSEcCtD
Zoledronate—Erythema—Topiramate—epilepsy syndrome	4.69e-05	0.000217	CcSEcCtD
Zoledronate—Malnutrition—Topiramate—epilepsy syndrome	4.69e-05	0.000217	CcSEcCtD
Zoledronate—Discomfort—Gabapentin—epilepsy syndrome	4.69e-05	0.000217	CcSEcCtD
Zoledronate—CA2—Metabolism—ST3GAL3—epilepsy syndrome	4.67e-05	0.000556	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—APOE—epilepsy syndrome	4.67e-05	0.000556	CbGpPWpGaD
Zoledronate—Headache—Oxcarbazepine—epilepsy syndrome	4.66e-05	0.000216	CcSEcCtD
Zoledronate—Nausea—Zonisamide—epilepsy syndrome	4.64e-05	0.000215	CcSEcCtD
Zoledronate—Dry mouth—Gabapentin—epilepsy syndrome	4.64e-05	0.000215	CcSEcCtD
Zoledronate—Hypotension—Pregabalin—epilepsy syndrome	4.63e-05	0.000215	CcSEcCtD
Zoledronate—ABCC1—Disease—PNPO—epilepsy syndrome	4.6e-05	0.000548	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EPM2A—epilepsy syndrome	4.6e-05	0.000548	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NHLRC1—epilepsy syndrome	4.6e-05	0.000548	CbGpPWpGaD
Zoledronate—Dysgeusia—Topiramate—epilepsy syndrome	4.59e-05	0.000213	CcSEcCtD
Zoledronate—Confusional state—Gabapentin—epilepsy syndrome	4.59e-05	0.000212	CcSEcCtD
Zoledronate—CA2—Metabolism—ADSL—epilepsy syndrome	4.58e-05	0.000544	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ABCG2—epilepsy syndrome	4.58e-05	0.000544	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.57e-05	0.000544	CbGpPWpGaD
Zoledronate—Dizziness—Lamotrigine—epilepsy syndrome	4.57e-05	0.000211	CcSEcCtD
Zoledronate—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.55e-05	0.000211	CcSEcCtD
Zoledronate—Oedema—Gabapentin—epilepsy syndrome	4.55e-05	0.000211	CcSEcCtD
Zoledronate—Vomiting—Carbamazepine—epilepsy syndrome	4.54e-05	0.00021	CcSEcCtD
Zoledronate—Back pain—Topiramate—epilepsy syndrome	4.54e-05	0.00021	CcSEcCtD
Zoledronate—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.52e-05	0.000209	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.52e-05	0.000209	CcSEcCtD
Zoledronate—Infection—Gabapentin—epilepsy syndrome	4.52e-05	0.000209	CcSEcCtD
Zoledronate—Muscle spasms—Topiramate—epilepsy syndrome	4.51e-05	0.000209	CcSEcCtD
Zoledronate—Rash—Carbamazepine—epilepsy syndrome	4.5e-05	0.000209	CcSEcCtD
Zoledronate—Dermatitis—Carbamazepine—epilepsy syndrome	4.5e-05	0.000208	CcSEcCtD
Zoledronate—CA2—Metabolism—GLUL—epilepsy syndrome	4.49e-05	0.000534	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.49e-05	0.000208	CcSEcCtD
Zoledronate—Insomnia—Pregabalin—epilepsy syndrome	4.49e-05	0.000208	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	4.48e-05	0.000533	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.48e-05	0.000533	CbGpPWpGaD
Zoledronate—Nausea—Clonazepam—epilepsy syndrome	4.48e-05	0.000207	CcSEcCtD
Zoledronate—Headache—Carbamazepine—epilepsy syndrome	4.48e-05	0.000207	CcSEcCtD
Zoledronate—Shock—Gabapentin—epilepsy syndrome	4.47e-05	0.000207	CcSEcCtD
Zoledronate—Nervous system disorder—Gabapentin—epilepsy syndrome	4.46e-05	0.000206	CcSEcCtD
Zoledronate—CA14—Metabolism—CYP2C19—epilepsy syndrome	4.46e-05	0.00053	CbGpPWpGaD
Zoledronate—Paraesthesia—Pregabalin—epilepsy syndrome	4.45e-05	0.000206	CcSEcCtD
Zoledronate—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.45e-05	0.000206	CcSEcCtD
Zoledronate—Nausea—Phenytoin—epilepsy syndrome	4.45e-05	0.000206	CcSEcCtD
Zoledronate—Tachycardia—Gabapentin—epilepsy syndrome	4.44e-05	0.000206	CcSEcCtD
Zoledronate—CA14—Metabolism—CYP11A1—epilepsy syndrome	4.43e-05	0.000527	CbGpPWpGaD
Zoledronate—Dyspnoea—Pregabalin—epilepsy syndrome	4.42e-05	0.000205	CcSEcCtD
Zoledronate—Nausea—Oxcarbazepine—epilepsy syndrome	4.42e-05	0.000205	CcSEcCtD
Zoledronate—Vision blurred—Topiramate—epilepsy syndrome	4.42e-05	0.000205	CcSEcCtD
Zoledronate—Skin disorder—Gabapentin—epilepsy syndrome	4.42e-05	0.000205	CcSEcCtD
Zoledronate—Somnolence—Pregabalin—epilepsy syndrome	4.41e-05	0.000204	CcSEcCtD
Zoledronate—CA2—Metabolism—CACNA1D—epilepsy syndrome	4.4e-05	0.000524	CbGpPWpGaD
Zoledronate—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.4e-05	0.000204	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	4.4e-05	0.000523	CbGpPWpGaD
Zoledronate—Tremor—Topiramate—epilepsy syndrome	4.39e-05	0.000203	CcSEcCtD
Zoledronate—Vomiting—Lamotrigine—epilepsy syndrome	4.39e-05	0.000203	CcSEcCtD
Zoledronate—Urticaria—Valproic Acid—epilepsy syndrome	4.36e-05	0.000202	CcSEcCtD
Zoledronate—Rash—Lamotrigine—epilepsy syndrome	4.35e-05	0.000202	CcSEcCtD
Zoledronate—Ill-defined disorder—Topiramate—epilepsy syndrome	4.35e-05	0.000201	CcSEcCtD
Zoledronate—Dermatitis—Lamotrigine—epilepsy syndrome	4.35e-05	0.000201	CcSEcCtD
Zoledronate—Body temperature increased—Valproic Acid—epilepsy syndrome	4.34e-05	0.000201	CcSEcCtD
Zoledronate—Abdominal pain—Valproic Acid—epilepsy syndrome	4.34e-05	0.000201	CcSEcCtD
Zoledronate—Anorexia—Gabapentin—epilepsy syndrome	4.34e-05	0.000201	CcSEcCtD
Zoledronate—Anaemia—Topiramate—epilepsy syndrome	4.33e-05	0.000201	CcSEcCtD
Zoledronate—Headache—Lamotrigine—epilepsy syndrome	4.33e-05	0.0002	CcSEcCtD
Zoledronate—Decreased appetite—Pregabalin—epilepsy syndrome	4.31e-05	0.0002	CcSEcCtD
Zoledronate—Agitation—Topiramate—epilepsy syndrome	4.31e-05	0.000199	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.28e-05	0.000198	CcSEcCtD
Zoledronate—ABCC1—Disease—SV2A—epilepsy syndrome	4.28e-05	0.000509	CbGpPWpGaD
Zoledronate—Fatigue—Pregabalin—epilepsy syndrome	4.28e-05	0.000198	CcSEcCtD
Zoledronate—Hypotension—Gabapentin—epilepsy syndrome	4.25e-05	0.000197	CcSEcCtD
Zoledronate—Nausea—Carbamazepine—epilepsy syndrome	4.24e-05	0.000196	CcSEcCtD
Zoledronate—Pain—Pregabalin—epilepsy syndrome	4.24e-05	0.000196	CcSEcCtD
Zoledronate—Constipation—Pregabalin—epilepsy syndrome	4.24e-05	0.000196	CcSEcCtD
Zoledronate—Malaise—Topiramate—epilepsy syndrome	4.23e-05	0.000196	CcSEcCtD
Zoledronate—ABCC1—Metabolism—L2HGDH—epilepsy syndrome	4.22e-05	0.000502	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PDXK—epilepsy syndrome	4.22e-05	0.000502	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADK—epilepsy syndrome	4.22e-05	0.000502	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FAR1—epilepsy syndrome	4.22e-05	0.000502	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GLUD1—epilepsy syndrome	4.22e-05	0.000502	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CERS1—epilepsy syndrome	4.22e-05	0.000502	CbGpPWpGaD
Zoledronate—Vertigo—Topiramate—epilepsy syndrome	4.21e-05	0.000195	CcSEcCtD
Zoledronate—Syncope—Topiramate—epilepsy syndrome	4.2e-05	0.000195	CcSEcCtD
Zoledronate—Leukopenia—Topiramate—epilepsy syndrome	4.2e-05	0.000194	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	4.19e-05	0.000499	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.14e-05	0.000192	CcSEcCtD
Zoledronate—Palpitations—Topiramate—epilepsy syndrome	4.14e-05	0.000192	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	4.13e-05	0.000492	CbGpPWpGaD
Zoledronate—Loss of consciousness—Topiramate—epilepsy syndrome	4.12e-05	0.000191	CcSEcCtD
Zoledronate—CA2—Metabolism—TXNRD1—epilepsy syndrome	4.12e-05	0.00049	CbGpPWpGaD
Zoledronate—Insomnia—Gabapentin—epilepsy syndrome	4.11e-05	0.00019	CcSEcCtD
Zoledronate—Nausea—Lamotrigine—epilepsy syndrome	4.1e-05	0.00019	CcSEcCtD
Zoledronate—Cough—Topiramate—epilepsy syndrome	4.09e-05	0.000189	CcSEcCtD
Zoledronate—Feeling abnormal—Pregabalin—epilepsy syndrome	4.09e-05	0.000189	CcSEcCtD
Zoledronate—Paraesthesia—Gabapentin—epilepsy syndrome	4.08e-05	0.000189	CcSEcCtD
Zoledronate—Convulsion—Topiramate—epilepsy syndrome	4.06e-05	0.000188	CcSEcCtD
Zoledronate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.06e-05	0.000188	CcSEcCtD
Zoledronate—Dyspnoea—Gabapentin—epilepsy syndrome	4.05e-05	0.000188	CcSEcCtD
Zoledronate—Hypertension—Topiramate—epilepsy syndrome	4.05e-05	0.000187	CcSEcCtD
Zoledronate—Somnolence—Gabapentin—epilepsy syndrome	4.04e-05	0.000187	CcSEcCtD
Zoledronate—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.04e-05	0.000187	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.02e-05	0.000478	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—POMC—epilepsy syndrome	4.01e-05	0.000477	CbGpPWpGaD
Zoledronate—Dyspepsia—Gabapentin—epilepsy syndrome	4e-05	0.000185	CcSEcCtD
Zoledronate—CA2—Metabolism—AQP1—epilepsy syndrome	4e-05	0.000476	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP2D6—epilepsy syndrome	4e-05	0.000476	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ABCG2—epilepsy syndrome	4e-05	0.000476	CbGpPWpGaD
Zoledronate—Chest pain—Topiramate—epilepsy syndrome	3.99e-05	0.000185	CcSEcCtD
Zoledronate—Myalgia—Topiramate—epilepsy syndrome	3.99e-05	0.000185	CcSEcCtD
Zoledronate—Arthralgia—Topiramate—epilepsy syndrome	3.99e-05	0.000185	CcSEcCtD
Zoledronate—Anxiety—Topiramate—epilepsy syndrome	3.98e-05	0.000184	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.96e-05	0.000184	CcSEcCtD
Zoledronate—Decreased appetite—Gabapentin—epilepsy syndrome	3.95e-05	0.000183	CcSEcCtD
Zoledronate—Discomfort—Topiramate—epilepsy syndrome	3.94e-05	0.000183	CcSEcCtD
Zoledronate—Urticaria—Pregabalin—epilepsy syndrome	3.94e-05	0.000182	CcSEcCtD
Zoledronate—Asthenia—Valproic Acid—epilepsy syndrome	3.94e-05	0.000182	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.93e-05	0.000182	CcSEcCtD
Zoledronate—Fatigue—Gabapentin—epilepsy syndrome	3.92e-05	0.000182	CcSEcCtD
Zoledronate—Body temperature increased—Pregabalin—epilepsy syndrome	3.92e-05	0.000182	CcSEcCtD
Zoledronate—Abdominal pain—Pregabalin—epilepsy syndrome	3.92e-05	0.000182	CcSEcCtD
Zoledronate—Dry mouth—Topiramate—epilepsy syndrome	3.9e-05	0.000181	CcSEcCtD
Zoledronate—FDPS—Metabolism—CYP2C19—epilepsy syndrome	3.9e-05	0.000464	CbGpPWpGaD
Zoledronate—Constipation—Gabapentin—epilepsy syndrome	3.89e-05	0.00018	CcSEcCtD
Zoledronate—Pain—Gabapentin—epilepsy syndrome	3.89e-05	0.00018	CcSEcCtD
Zoledronate—Pruritus—Valproic Acid—epilepsy syndrome	3.88e-05	0.00018	CcSEcCtD
Zoledronate—FDPS—Metabolism—CYP11A1—epilepsy syndrome	3.87e-05	0.000461	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.87e-05	0.00046	CbGpPWpGaD
Zoledronate—Confusional state—Topiramate—epilepsy syndrome	3.86e-05	0.000179	CcSEcCtD
Zoledronate—ABCC1—Metabolism—EPM2A—epilepsy syndrome	3.86e-05	0.000459	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GAMT—epilepsy syndrome	3.86e-05	0.000459	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PNPO—epilepsy syndrome	3.86e-05	0.000459	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NHLRC1—epilepsy syndrome	3.86e-05	0.000459	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCG2—epilepsy syndrome	3.86e-05	0.000459	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.85e-05	0.000457	CbGpPWpGaD
Zoledronate—Oedema—Topiramate—epilepsy syndrome	3.83e-05	0.000177	CcSEcCtD
Zoledronate—ABCC1—Disease—PFKL—epilepsy syndrome	3.82e-05	0.000454	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ADRA2A—epilepsy syndrome	3.81e-05	0.000453	CbGpPWpGaD
Zoledronate—Infection—Topiramate—epilepsy syndrome	3.8e-05	0.000176	CcSEcCtD
Zoledronate—CA14—Metabolism—BCHE—epilepsy syndrome	3.79e-05	0.000451	CbGpPWpGaD
Zoledronate—Shock—Topiramate—epilepsy syndrome	3.76e-05	0.000174	CcSEcCtD
Zoledronate—CA12—Metabolism—CYP2C19—epilepsy syndrome	3.76e-05	0.000447	CbGpPWpGaD
Zoledronate—Diarrhoea—Valproic Acid—epilepsy syndrome	3.75e-05	0.000174	CcSEcCtD
Zoledronate—Nervous system disorder—Topiramate—epilepsy syndrome	3.75e-05	0.000174	CcSEcCtD
Zoledronate—Feeling abnormal—Gabapentin—epilepsy syndrome	3.75e-05	0.000174	CcSEcCtD
Zoledronate—Thrombocytopenia—Topiramate—epilepsy syndrome	3.75e-05	0.000173	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.74e-05	0.000445	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.74e-05	0.000445	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP11A1—epilepsy syndrome	3.73e-05	0.000444	CbGpPWpGaD
Zoledronate—Tachycardia—Topiramate—epilepsy syndrome	3.73e-05	0.000173	CcSEcCtD
Zoledronate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.72e-05	0.000172	CcSEcCtD
Zoledronate—Skin disorder—Topiramate—epilepsy syndrome	3.72e-05	0.000172	CcSEcCtD
Zoledronate—Hyperhidrosis—Topiramate—epilepsy syndrome	3.7e-05	0.000171	CcSEcCtD
Zoledronate—GGPS1—Metabolism—ALB—epilepsy syndrome	3.66e-05	0.000435	CbGpPWpGaD
Zoledronate—Hypersensitivity—Pregabalin—epilepsy syndrome	3.65e-05	0.000169	CcSEcCtD
Zoledronate—Anorexia—Topiramate—epilepsy syndrome	3.65e-05	0.000169	CcSEcCtD
Zoledronate—Dizziness—Valproic Acid—epilepsy syndrome	3.63e-05	0.000168	CcSEcCtD
Zoledronate—CA2—Metabolism—KCNJ11—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CHRM3—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Zoledronate—CA14—Metabolism—SLC2A1—epilepsy syndrome	3.62e-05	0.00043	CbGpPWpGaD
Zoledronate—Urticaria—Gabapentin—epilepsy syndrome	3.61e-05	0.000167	CcSEcCtD
Zoledronate—Abdominal pain—Gabapentin—epilepsy syndrome	3.6e-05	0.000166	CcSEcCtD
Zoledronate—Body temperature increased—Gabapentin—epilepsy syndrome	3.6e-05	0.000166	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CA4—epilepsy syndrome	3.59e-05	0.000427	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—QDPR—epilepsy syndrome	3.59e-05	0.000427	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.58e-05	0.000426	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PLCB1—epilepsy syndrome	3.58e-05	0.000426	CbGpPWpGaD
Zoledronate—Hypotension—Topiramate—epilepsy syndrome	3.58e-05	0.000166	CcSEcCtD
Zoledronate—CA14—Metabolism—TH—epilepsy syndrome	3.56e-05	0.000424	CbGpPWpGaD
Zoledronate—Asthenia—Pregabalin—epilepsy syndrome	3.56e-05	0.000165	CcSEcCtD
Zoledronate—Pruritus—Pregabalin—epilepsy syndrome	3.51e-05	0.000162	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.51e-05	0.000417	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP2D6—epilepsy syndrome	3.5e-05	0.000416	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STX1B—epilepsy syndrome	3.49e-05	0.000415	CbGpPWpGaD
Zoledronate—Vomiting—Valproic Acid—epilepsy syndrome	3.49e-05	0.000161	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.49e-05	0.000161	CcSEcCtD
Zoledronate—Insomnia—Topiramate—epilepsy syndrome	3.46e-05	0.00016	CcSEcCtD
Zoledronate—Rash—Valproic Acid—epilepsy syndrome	3.46e-05	0.00016	CcSEcCtD
Zoledronate—Dermatitis—Valproic Acid—epilepsy syndrome	3.46e-05	0.00016	CcSEcCtD
Zoledronate—Headache—Valproic Acid—epilepsy syndrome	3.44e-05	0.000159	CcSEcCtD
Zoledronate—Paraesthesia—Topiramate—epilepsy syndrome	3.44e-05	0.000159	CcSEcCtD
Zoledronate—Dyspnoea—Topiramate—epilepsy syndrome	3.41e-05	0.000158	CcSEcCtD
Zoledronate—Somnolence—Topiramate—epilepsy syndrome	3.4e-05	0.000157	CcSEcCtD
Zoledronate—Diarrhoea—Pregabalin—epilepsy syndrome	3.39e-05	0.000157	CcSEcCtD
Zoledronate—ABCC1—Metabolism—COX3—epilepsy syndrome	3.37e-05	0.000401	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP2D6—epilepsy syndrome	3.37e-05	0.000401	CbGpPWpGaD
Zoledronate—Dyspepsia—Topiramate—epilepsy syndrome	3.37e-05	0.000156	CcSEcCtD
Zoledronate—Hypersensitivity—Gabapentin—epilepsy syndrome	3.35e-05	0.000155	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.33e-05	0.000396	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ADRA2A—epilepsy syndrome	3.33e-05	0.000396	CbGpPWpGaD
Zoledronate—Decreased appetite—Topiramate—epilepsy syndrome	3.33e-05	0.000154	CcSEcCtD
Zoledronate—FDPS—Metabolism—BCHE—epilepsy syndrome	3.31e-05	0.000394	CbGpPWpGaD
Zoledronate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.3e-05	0.000153	CcSEcCtD
Zoledronate—Fatigue—Topiramate—epilepsy syndrome	3.3e-05	0.000153	CcSEcCtD
Zoledronate—Dizziness—Pregabalin—epilepsy syndrome	3.28e-05	0.000152	CcSEcCtD
Zoledronate—Pain—Topiramate—epilepsy syndrome	3.27e-05	0.000151	CcSEcCtD
Zoledronate—Constipation—Topiramate—epilepsy syndrome	3.27e-05	0.000151	CcSEcCtD
Zoledronate—Asthenia—Gabapentin—epilepsy syndrome	3.26e-05	0.000151	CcSEcCtD
Zoledronate—Nausea—Valproic Acid—epilepsy syndrome	3.26e-05	0.000151	CcSEcCtD
Zoledronate—ABCC1—Disease—CPSF4—epilepsy syndrome	3.24e-05	0.000386	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PPP1R3C—epilepsy syndrome	3.24e-05	0.000386	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GBE1—epilepsy syndrome	3.24e-05	0.000386	CbGpPWpGaD
Zoledronate—Pruritus—Gabapentin—epilepsy syndrome	3.22e-05	0.000149	CcSEcCtD
Zoledronate—CA12—Metabolism—ADRA2A—epilepsy syndrome	3.21e-05	0.000382	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PTGS2—epilepsy syndrome	3.2e-05	0.000381	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PFKL—epilepsy syndrome	3.2e-05	0.00038	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—KCNB1—epilepsy syndrome	3.2e-05	0.00038	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CACNA2D2—epilepsy syndrome	3.2e-05	0.00038	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLCO1A2—epilepsy syndrome	3.2e-05	0.00038	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC6A8—epilepsy syndrome	3.2e-05	0.00038	CbGpPWpGaD
Zoledronate—CA12—Metabolism—BCHE—epilepsy syndrome	3.2e-05	0.00038	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—SLC2A1—epilepsy syndrome	3.16e-05	0.000376	CbGpPWpGaD
Zoledronate—Vomiting—Pregabalin—epilepsy syndrome	3.15e-05	0.000146	CcSEcCtD
Zoledronate—Feeling abnormal—Topiramate—epilepsy syndrome	3.15e-05	0.000146	CcSEcCtD
Zoledronate—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.13e-05	0.000145	CcSEcCtD
Zoledronate—Rash—Pregabalin—epilepsy syndrome	3.13e-05	0.000145	CcSEcCtD
Zoledronate—FDPS—Metabolism—PLCB1—epilepsy syndrome	3.13e-05	0.000372	CbGpPWpGaD
Zoledronate—Dermatitis—Pregabalin—epilepsy syndrome	3.12e-05	0.000145	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.12e-05	0.000372	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—TH—epilepsy syndrome	3.12e-05	0.000371	CbGpPWpGaD
Zoledronate—Diarrhoea—Gabapentin—epilepsy syndrome	3.11e-05	0.000144	CcSEcCtD
Zoledronate—Headache—Pregabalin—epilepsy syndrome	3.11e-05	0.000144	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.1e-05	0.000369	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.07e-05	0.000365	CbGpPWpGaD
Zoledronate—CA12—Metabolism—SLC2A1—epilepsy syndrome	3.05e-05	0.000363	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.05e-05	0.000363	CbGpPWpGaD
Zoledronate—Urticaria—Topiramate—epilepsy syndrome	3.04e-05	0.000141	CcSEcCtD
Zoledronate—Abdominal pain—Topiramate—epilepsy syndrome	3.02e-05	0.00014	CcSEcCtD
Zoledronate—Body temperature increased—Topiramate—epilepsy syndrome	3.02e-05	0.00014	CcSEcCtD
Zoledronate—CA12—Metabolism—PLCB1—epilepsy syndrome	3.02e-05	0.000359	CbGpPWpGaD
Zoledronate—Dizziness—Gabapentin—epilepsy syndrome	3.01e-05	0.000139	CcSEcCtD
Zoledronate—CA12—Metabolism—TH—epilepsy syndrome	3e-05	0.000357	CbGpPWpGaD
Zoledronate—CA14—Metabolism—HMOX1—epilepsy syndrome	2.97e-05	0.000354	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.97e-05	0.000353	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCG2—epilepsy syndrome	2.95e-05	0.000351	CbGpPWpGaD
Zoledronate—Nausea—Pregabalin—epilepsy syndrome	2.95e-05	0.000136	CcSEcCtD
Zoledronate—CA14—Metabolism—CAT—epilepsy syndrome	2.94e-05	0.000349	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UPB1—epilepsy syndrome	2.92e-05	0.000348	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NEU1—epilepsy syndrome	2.92e-05	0.000348	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ATIC—epilepsy syndrome	2.92e-05	0.000348	CbGpPWpGaD
Zoledronate—Vomiting—Gabapentin—epilepsy syndrome	2.89e-05	0.000134	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP2C19—epilepsy syndrome	2.87e-05	0.000342	CbGpPWpGaD
Zoledronate—Rash—Gabapentin—epilepsy syndrome	2.87e-05	0.000133	CcSEcCtD
Zoledronate—Dermatitis—Gabapentin—epilepsy syndrome	2.87e-05	0.000133	CcSEcCtD
Zoledronate—CA14—Metabolism—ABCB1—epilepsy syndrome	2.86e-05	0.00034	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP11A1—epilepsy syndrome	2.86e-05	0.00034	CbGpPWpGaD
Zoledronate—Headache—Gabapentin—epilepsy syndrome	2.85e-05	0.000132	CcSEcCtD
Zoledronate—Hypersensitivity—Topiramate—epilepsy syndrome	2.82e-05	0.000131	CcSEcCtD
Zoledronate—ABCC1—Metabolism—HSD17B4—epilepsy syndrome	2.81e-05	0.000335	CbGpPWpGaD
Zoledronate—Asthenia—Topiramate—epilepsy syndrome	2.75e-05	0.000127	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PPP1R3C—epilepsy syndrome	2.72e-05	0.000323	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GBE1—epilepsy syndrome	2.72e-05	0.000323	CbGpPWpGaD
Zoledronate—Pruritus—Topiramate—epilepsy syndrome	2.71e-05	0.000125	CcSEcCtD
Zoledronate—Nausea—Gabapentin—epilepsy syndrome	2.7e-05	0.000125	CcSEcCtD
Zoledronate—ABCC1—Disease—ST3GAL3—epilepsy syndrome	2.7e-05	0.000321	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.66e-05	0.000316	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GPX1—epilepsy syndrome	2.65e-05	0.000316	CbGpPWpGaD
Zoledronate—Diarrhoea—Topiramate—epilepsy syndrome	2.62e-05	0.000121	CcSEcCtD
Zoledronate—FDPS—Metabolism—HMOX1—epilepsy syndrome	2.6e-05	0.000309	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP2D6—epilepsy syndrome	2.58e-05	0.000307	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CAT—epilepsy syndrome	2.57e-05	0.000305	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ASAH1—epilepsy syndrome	2.55e-05	0.000304	CbGpPWpGaD
Zoledronate—Dizziness—Topiramate—epilepsy syndrome	2.53e-05	0.000117	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.53e-05	0.0003	CbGpPWpGaD
Zoledronate—CA12—Metabolism—HMOX1—epilepsy syndrome	2.51e-05	0.000298	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ABCB1—epilepsy syndrome	2.5e-05	0.000297	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—STXBP1—epilepsy syndrome	2.49e-05	0.000296	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAT—epilepsy syndrome	2.47e-05	0.000294	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ADRA2A—epilepsy syndrome	2.45e-05	0.000292	CbGpPWpGaD
Zoledronate—CA2—Metabolism—BCHE—epilepsy syndrome	2.44e-05	0.000291	CbGpPWpGaD
Zoledronate—Vomiting—Topiramate—epilepsy syndrome	2.43e-05	0.000113	CcSEcCtD
Zoledronate—ABCC1—Metabolism—NT5E—epilepsy syndrome	2.42e-05	0.000288	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALAD—epilepsy syndrome	2.42e-05	0.000288	CbGpPWpGaD
Zoledronate—Rash—Topiramate—epilepsy syndrome	2.41e-05	0.000112	CcSEcCtD
Zoledronate—Dermatitis—Topiramate—epilepsy syndrome	2.41e-05	0.000112	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.41e-05	0.000287	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCB1—epilepsy syndrome	2.41e-05	0.000286	CbGpPWpGaD
Zoledronate—Headache—Topiramate—epilepsy syndrome	2.4e-05	0.000111	CcSEcCtD
Zoledronate—CA2—Metabolism—SLC2A1—epilepsy syndrome	2.33e-05	0.000277	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AGT—epilepsy syndrome	2.33e-05	0.000277	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GPX1—epilepsy syndrome	2.32e-05	0.000276	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDH7A1—epilepsy syndrome	2.31e-05	0.000275	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CACNA1A—epilepsy syndrome	2.31e-05	0.000275	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PLCB1—epilepsy syndrome	2.31e-05	0.000274	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TH—epilepsy syndrome	2.3e-05	0.000273	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOE—epilepsy syndrome	2.28e-05	0.000271	CbGpPWpGaD
Zoledronate—Nausea—Topiramate—epilepsy syndrome	2.27e-05	0.000105	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ST3GAL3—epilepsy syndrome	2.26e-05	0.000269	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GPX1—epilepsy syndrome	2.24e-05	0.000266	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADSL—epilepsy syndrome	2.21e-05	0.000263	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GLUL—epilepsy syndrome	2.17e-05	0.000258	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CACNA1D—epilepsy syndrome	2.13e-05	0.000254	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AGT—epilepsy syndrome	2.03e-05	0.000242	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TXNRD1—epilepsy syndrome	1.99e-05	0.000237	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOE—epilepsy syndrome	1.99e-05	0.000237	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.98e-05	0.000236	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EIF2AK2—epilepsy syndrome	1.97e-05	0.000234	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.96e-05	0.000234	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AGT—epilepsy syndrome	1.96e-05	0.000233	CbGpPWpGaD
Zoledronate—CA14—Metabolism—POMC—epilepsy syndrome	1.96e-05	0.000233	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AQP1—epilepsy syndrome	1.94e-05	0.00023	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOE—epilepsy syndrome	1.92e-05	0.000229	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HMOX1—epilepsy syndrome	1.92e-05	0.000228	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.9e-05	0.000226	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAT—epilepsy syndrome	1.89e-05	0.000225	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.86e-05	0.000221	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCB1—epilepsy syndrome	1.84e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PPIA—epilepsy syndrome	1.82e-05	0.000216	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—epilepsy syndrome	1.79e-05	0.000213	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—KCNJ11—epilepsy syndrome	1.75e-05	0.000208	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CHRM3—epilepsy syndrome	1.75e-05	0.000208	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—POMC—epilepsy syndrome	1.71e-05	0.000204	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPX1—epilepsy syndrome	1.71e-05	0.000204	CbGpPWpGaD
Zoledronate—CA12—Metabolism—POMC—epilepsy syndrome	1.65e-05	0.000196	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.63e-05	0.000194	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—epilepsy syndrome	1.61e-05	0.000191	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.6e-05	0.00019	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—epilepsy syndrome	1.56e-05	0.000186	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALB—epilepsy syndrome	1.56e-05	0.000186	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—epilepsy syndrome	1.51e-05	0.000179	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AGT—epilepsy syndrome	1.5e-05	0.000178	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOE—epilepsy syndrome	1.47e-05	0.000175	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCG2—epilepsy syndrome	1.43e-05	0.00017	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2C19—epilepsy syndrome	1.39e-05	0.000165	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP11A1—epilepsy syndrome	1.38e-05	0.000164	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.37e-05	0.000163	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—epilepsy syndrome	1.37e-05	0.000163	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC2A1—epilepsy syndrome	1.35e-05	0.00016	CbGpPWpGaD
Zoledronate—ABCC1—Disease—JUNB—epilepsy syndrome	1.34e-05	0.000159	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS1—epilepsy syndrome	1.33e-05	0.000158	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—epilepsy syndrome	1.32e-05	0.000157	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HBEGF—epilepsy syndrome	1.27e-05	0.000151	CbGpPWpGaD
Zoledronate—CA2—Metabolism—POMC—epilepsy syndrome	1.26e-05	0.00015	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.25e-05	0.000149	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2D6—epilepsy syndrome	1.25e-05	0.000148	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT3—epilepsy syndrome	1.24e-05	0.000148	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ADAM10—epilepsy syndrome	1.21e-05	0.000144	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.19e-05	0.000142	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADRA2A—epilepsy syndrome	1.19e-05	0.000141	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BCHE—epilepsy syndrome	1.18e-05	0.000141	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—epilepsy syndrome	1.15e-05	0.000137	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDC42—epilepsy syndrome	1.13e-05	0.000135	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC2A1—epilepsy syndrome	1.13e-05	0.000134	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLCB1—epilepsy syndrome	1.12e-05	0.000133	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TH—epilepsy syndrome	1.11e-05	0.000132	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.09e-05	0.00013	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HES1—epilepsy syndrome	1.04e-05	0.000124	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FYN—epilepsy syndrome	1.01e-05	0.00012	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—epilepsy syndrome	1.01e-05	0.00012	CbGpPWpGaD
Zoledronate—ABCC1—Disease—H2AFX—epilepsy syndrome	1.01e-05	0.00012	CbGpPWpGaD
Zoledronate—ABCC1—Disease—YWHAZ—epilepsy syndrome	9.71e-06	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CCR5—epilepsy syndrome	9.34e-06	0.000111	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMOX1—epilepsy syndrome	9.28e-06	0.00011	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAT—epilepsy syndrome	9.16e-06	0.000109	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCB1—epilepsy syndrome	8.91e-06	0.000106	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TSC2—epilepsy syndrome	8.68e-06	0.000103	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOE—epilepsy syndrome	8.5e-06	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPX1—epilepsy syndrome	8.28e-06	9.85e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6ST—epilepsy syndrome	7.98e-06	9.49e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS2—epilepsy syndrome	7.92e-06	9.42e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—epilepsy syndrome	7.85e-06	9.34e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AGT—epilepsy syndrome	7.26e-06	8.64e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOE—epilepsy syndrome	7.11e-06	8.46e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—epilepsy syndrome	6.87e-06	8.17e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—epilepsy syndrome	6.62e-06	7.88e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF2—epilepsy syndrome	6.45e-06	7.68e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—POMC—epilepsy syndrome	6.11e-06	7.27e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTOR—epilepsy syndrome	5.87e-06	6.99e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—epilepsy syndrome	5.82e-06	6.93e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—epilepsy syndrome	5.57e-06	6.63e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—epilepsy syndrome	5.06e-06	6.02e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—epilepsy syndrome	4.87e-06	5.8e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SRC—epilepsy syndrome	4.71e-06	5.6e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—epilepsy syndrome	2.93e-06	3.48e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—epilepsy syndrome	2.45e-06	2.91e-05	CbGpPWpGaD
